Fingerprint
Dive into the research topics of 'FDA Approval Summary: Atezolizumab plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically